{"resultsPerPage":1,"startIndex":0,"totalResults":1,"format":"NVD_CVE","version":"2.0","timestamp":"2026-05-10T21:51:29.007","vulnerabilities":[{"cve":{"id":"CVE-2020-27258","sourceIdentifier":"ics-cert@hq.dhs.gov","published":"2021-01-19T21:15:14.047","lastModified":"2024-11-21T05:20:57.400","vulnStatus":"Modified","cveTags":[],"descriptions":[{"lang":"en","value":"In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, an information disclosure vulnerability in the communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows unauthenticated attackers to extract the pump’s keypad lock PIN via Bluetooth Low Energy."},{"lang":"es","value":"En SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i y AnyDana-A, una vulnerabilidad de divulgación de información en el protocolo de comunicación de la bomba de insulina y sus aplicaciones móviles AnyDana-i y AnyDana-A permite a atacantes no autenticados extraer el bloqueo del teclado de la bomba. PIN por medio de Bluetooth Low Energy"}],"metrics":{"cvssMetricV31":[{"source":"nvd@nist.gov","type":"Primary","cvssData":{"version":"3.1","vectorString":"CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N","baseScore":6.5,"baseSeverity":"MEDIUM","attackVector":"ADJACENT_NETWORK","attackComplexity":"LOW","privilegesRequired":"NONE","userInteraction":"NONE","scope":"UNCHANGED","confidentialityImpact":"HIGH","integrityImpact":"NONE","availabilityImpact":"NONE"},"exploitabilityScore":2.8,"impactScore":3.6}],"cvssMetricV2":[{"source":"nvd@nist.gov","type":"Primary","cvssData":{"version":"2.0","vectorString":"AV:A/AC:L/Au:N/C:P/I:N/A:N","baseScore":3.3,"accessVector":"ADJACENT_NETWORK","accessComplexity":"LOW","authentication":"NONE","confidentialityImpact":"PARTIAL","integrityImpact":"NONE","availabilityImpact":"NONE"},"baseSeverity":"LOW","exploitabilityScore":6.5,"impactScore":2.9,"acInsufInfo":false,"obtainAllPrivilege":false,"obtainUserPrivilege":false,"obtainOtherPrivilege":false,"userInteractionRequired":false}]},"weaknesses":[{"source":"ics-cert@hq.dhs.gov","type":"Secondary","description":[{"lang":"en","value":"CWE-522"}]},{"source":"nvd@nist.gov","type":"Primary","description":[{"lang":"en","value":"CWE-522"}]}],"configurations":[{"nodes":[{"operator":"OR","negate":false,"cpeMatch":[{"vulnerable":true,"criteria":"cpe:2.3:a:sooil:anydana-a:*:*:*:*:*:*:*:*","versionEndExcluding":"3.0","matchCriteriaId":"712D6D9A-8A9A-412A-94B0-54DCD142C5B1"},{"vulnerable":true,"criteria":"cpe:2.3:a:sooil:anydana-i:*:*:*:*:*:*:*:*","versionEndExcluding":"3.0","matchCriteriaId":"0C1AA992-E68C-4A87-8C9A-F487376D8825"}]}]},{"operator":"AND","nodes":[{"operator":"OR","negate":false,"cpeMatch":[{"vulnerable":true,"criteria":"cpe:2.3:o:sooil:dana_diabecare_rs_firmware:*:*:*:*:*:*:*:*","versionEndExcluding":"3.0","matchCriteriaId":"110D70B7-66A1-4DF0-B080-F0C95FA98B3F"}]},{"operator":"OR","negate":false,"cpeMatch":[{"vulnerable":false,"criteria":"cpe:2.3:h:sooil:dana_diabecare_rs:-:*:*:*:*:*:*:*","matchCriteriaId":"84960250-D074-4153-902D-C8C27A948076"}]}]}],"references":[{"url":"https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01","source":"ics-cert@hq.dhs.gov","tags":["Third Party Advisory","US Government Resource"]},{"url":"https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01","source":"af854a3a-2127-422b-91ae-364da2661108","tags":["Third Party Advisory","US Government Resource"]}]}}]}